The serum APN also significantly decreased in AD patients (Teixeira et al., 2013), and APN was protective against amyloid β-induced neurotoxicity in Alzheimer’s disease through AMPK activation and NF-κB suppression (Chan et al., 2012). Here, NFKB1 is linked to Alzheimer disease.